Synonyms:
Status: Phase 2
Entry Type: Antibody
Molecule Category: UNKNOWN

Pharmacology

Action Mechanism of Action Reference
BINDING AGENT Interleukin-2 receptor alpha chain binding agent PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Leukemia 2 D007938 ClinicalTrials
Lymphoma 2 D008223 ClinicalTrials
Leukemia, Hairy Cell 2 D007943 ClinicalTrials
Leukemia-Lymphoma, Adult T-Cell 1 D015459 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL2109367